HIV Prevention Crisis: The Fallout of U.S. Aid Cuts in Africa

Emmanuel Cherem, a gay man in Nigeria, recently tested positive for HIV following U.S. policy changes under Trump's administration. These changes halted life-saving drugs like Pre-Exposure Prophylaxis (PrEP), crucial in reducing HIV risk. The cuts, affecting vulnerable groups, are threatening Africa's progress against AIDS.

Emmanuel Cherem, a 25-year-old Nigerian, is among those suffering the consequences of U.S. cuts to HIV prevention aid. Diagnosed with HIV after access to vital medications was curtailed, Cherem reflects on the short-sightedness of policy changes that have endangered vulnerable populations.

Under the Trump administration, the U.S. reduced foreign aid for HIV prevention, impacting millions in sub-Saharan Africa. Programs like the President's Emergency Plan for AIDS Relief (PEPFAR) were central to providing life-saving medication, but cuts have left high-risk groups exposed.

Despite global efforts to control AIDS, the recent funding limitations pose a significant threat to progress. With dwindling resources, local health systems struggle, and the rate of new infections could surge. This policy shift prioritizes domestic financial constraints over international health solidarity.

(With inputs from agencies.)